Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

AniCura Varde Dyrehospital ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   19.6% 0.5% 0.8% 0.5% 3.2% 0.7% 4.6% 4.5%   Credit score (0-100)   8 98 93 99 55 93 45 45   Credit rating   B AA AA AAA BBB AA BBB BBB   Credit limit (kDKK)   0.0 2,280.2 1,937.2 2,158.1 0.0 1,298.6 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -15.0 12,135 16,441 18,385 19,578 23,191 0.0 0.0   EBITDA   -15.0 2,893 2,973 4,654 -3,528 4,139 0.0 0.0   EBIT   -15.0 802 110 1,703 -6,919 501 0.0 0.0   Pre-tax profit (PTP)   -15.0 839.3 139.9 1,758.7 -6,870.4 525.0 0.0 0.0   Net earnings   -12.0 650.7 106.6 1,368.5 -5,360.3 371.7 0.0 0.0   Pre-tax profit without non-rec. items   -15.0 839 140 1,759 -6,870 525 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   0.0 4,926 4,157 3,189 3,125 3,852 0.0 0.0   Shareholders equity total   27.0 20,058 19,324 17,192 8,832 9,204 9,154 9,154   Interest-bearing liabilities   0.0 639 355 16.0 3,129 3,866 0.0 0.0   Balance sheet total (assets)   57.0 24,825 23,289 21,427 19,542 19,510 9,154 9,154   Net Debt   0.0 -131 187 -298 2,863 3,679 -1,981 -1,981     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -15.0 12,135 16,441 18,385 19,578 23,191 0.0 0.0   Gross profit growth   0.0% 0.0% 35.5% 11.8% 6.5% 18.5% -100.0% 0.0%   Employees   0 19 26 26 28 34 0 0   Employee growth %   0.0% 0.0% 36.8% 0.0% 7.7% 21.4% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   57 24,825 23,289 21,427 19,542 19,510 9,154 9,154   Balance sheet change%   0.0% 43,452.7% -6.2% -8.0% -8.8% -0.2% -53.1% 0.0%   Added value   -15.0 802.2 109.8 1,703.0 -6,918.7 501.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 18,367 -5,227 -5,618 -5,912 -5,519 -3,852 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 2.0 3.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 6.6% 0.7% 9.3% -35.3% 2.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -26.3% 6.9% 0.7% 8.0% -33.5% 2.8% 0.0% 0.0%   ROI %   -55.6% 8.1% 0.8% 9.3% -44.0% 4.2% 0.0% 0.0%   ROE %   -44.4% 6.5% 0.5% 7.5% -41.2% 4.1% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   47.4% 80.8% 83.0% 80.2% 45.2% 47.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% -4.5% 6.3% -6.4% -81.2% 88.9% 0.0% 0.0%   Gearing %   0.0% 3.2% 1.8% 0.1% 35.4% 42.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 5.8% 5.6% 16.2% 0.3% 0.5% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   1.9 0.8 1.3 1.6 0.6 0.7 0.0 0.0   Current Ratio   1.9 1.0 1.5 1.8 0.7 0.8 0.0 0.0   Cash and cash equivalent   0.0 769.4 168.7 313.9 265.3 186.4 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   27.0 -18.5 1,758.0 2,742.4 -3,064.3 -1,830.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 42 4 66 -247 15 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 152 114 179 -126 122 0 0   EBIT / employee   0 42 4 66 -247 15 0 0   Net earnings / employee   0 34 4 53 -191 11 0 0